Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

Completed · Phase 3

Conditions studied: Hypertension

In brief

This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age

Key facts

Study ID

NCT00185133

Run by

Daiichi Sankyo

People needed

1900

Starts

2005-05-01

Expected to finish

2007-01-01

Last updated by the study team

2018-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients
• 18 years of age or older (20% equal to or older than 65 years)
• With mild to severe hypertension defined as seated diastolic blood pressure of 95-120 mmHg while off any hypertensive medication

You may not qualify if…

• Patients should not have serious concomitant conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patients

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Mobile, Alabama, United States
• Study site — Muscle Shoals, Alabama, United States
• Study site — Tuscumbia, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Anaheim, California, United States
• Study site — Beverly Hills, California, United States
• Study site — Buena Park, California, United States
• Study site — Cypress, California, United States
• Study site — Encino, California, United States
• Study site — Fountain Valley, California, United States
• Study site — La Jolla, California, United States
• Study site — Long Beach, California, United States
• Study site — Los Angeles, California, United States
• Study site — Los Gatos, California, United States
• Study site — Pico Rivera, California, United States
• Study site — Rancho Mirage, California, United States
• Study site — Roseville, California, United States
• Study site — Sacramento, California, United States
• Study site — San Francisco, California, United States
• Study site — Santa Ana, California, United States
• Study site — Spring Valley, California, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.